5 insiders reported 131 Form 4 transactions for BELITE BIO, INC (BLTE) over the past 18 months (most recent 2026-08-14). Recent activity: Lin Yu-Hsin (Chief Executive Officer) Sell 142 shares, Chuang Hao-Yuan (Chief Financial Officer) Sell 144 shares, Lin Yu-Hsin (Chief Executive Officer) Sell 223 shares, Chuang Hao-Yuan (Chief Financial Officer) Sell 223 shares, Scholl Hendrik Peter (Chief Medical Officer) Sell 96 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-14 | Lin Yu-Hsin | Chief Executive Officer | Sell | 142 | $25,560 |
| 2026-08-14 | Chuang Hao-Yuan | Chief Financial Officer | Sell | 144 | $25,920 |
| 2026-08-14 | Lin Yu-Hsin | Chief Executive Officer | Sell | 223 | $40,267 |
| 2026-08-14 | Chuang Hao-Yuan | Chief Financial Officer | Sell | 223 | $40,267 |
| 2026-06-22 | Scholl Hendrik Peter | Chief Medical Officer | Sell | 96 | $14,123 |
| 2026-06-22 | Scholl Hendrik Peter | Chief Medical Officer | Sell | 3,748 | $542,192 |
| 2026-06-22 | Scholl Hendrik Peter | Chief Medical Officer | Sell | 4,861 | $706,959 |
| 2026-06-22 | Scholl Hendrik Peter | Chief Medical Officer | Sell | 1,199 | $175,348 |
| 2026-06-22 | Scholl Hendrik Peter | Chief Medical Officer | Sell | 96 | $13,814 |
| 2026-06-17 | Scholl Hendrik Peter | Chief Medical Officer | Sell | 2,054 | $282,641 |
| 2026-06-17 | Scholl Hendrik Peter | Chief Medical Officer | Sell | 784 | $108,331 |
| 2026-06-17 | Scholl Hendrik Peter | Chief Medical Officer | Sell | 3,140 | $438,260 |
| 2026-06-17 | Scholl Hendrik Peter | Chief Medical Officer | Sell | 100 | $14,183 |
| 2026-06-17 | Scholl Hendrik Peter | Chief Medical Officer | Sell | 450 | $63,988 |
| 2026-06-17 | Scholl Hendrik Peter | Chief Medical Officer | Sell | 1,897 | $272,314 |
| 2026-06-17 | Scholl Hendrik Peter | Chief Medical Officer | Sell | 1,035 | $150,097 |
| 2026-06-17 | Scholl Hendrik Peter | Chief Medical Officer | Sell | 540 | $75,915 |
| 2026-05-08 | MATA NATHAN L. | Chief Scientific Officer | Sell | 226 | $34,453 |
| 2026-05-08 | MATA NATHAN L. | Chief Scientific Officer | Sell | 428 | $65,725 |
| 2026-05-08 | MATA NATHAN L. | Chief Scientific Officer | Sell | 3 | $464 |
| 2026-05-08 | MATA NATHAN L. | Chief Scientific Officer | Sell | 9 | $1,397 |
| 2026-05-07 | MATA NATHAN L. | Chief Scientific Officer | Sell | 240 | $37,059 |
| 2026-05-07 | MATA NATHAN L. | Chief Scientific Officer | Sell | 8 | $1,213 |
| 2026-05-07 | MATA NATHAN L. | Chief Scientific Officer | Sell | 424 | $64,733 |
| 2026-05-07 | MATA NATHAN L. | Chief Scientific Officer | Sell | 128 | $19,638 |
Source: SEC Form 4 filings · as of 2026-08-14